Page last updated: 2024-09-04

varespladib and Sepsis

varespladib has been researched along with Sepsis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, E; Dmitrienko, A; Fukiishi, Y; Laterre, PF; Steingrub, J; Zeiher, BG1

Trials

1 trial(s) available for varespladib and Sepsis

ArticleYear
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.
    Critical care medicine, 2005, Volume: 33, Issue:8

    Topics: Acetates; Double-Blind Method; Europe; Female; Group II Phospholipases A2; Humans; Indoles; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Risk; Sepsis; United States

2005